Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Common Equity (2016 - 2026)

InflaRx's Common Equity history spans 10 years, with the latest figure at $8.4 million for Q1 2026.

  • On a quarterly basis, Common Equity rose 9.26% to $8.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.4 million, a 9.26% increase, with the full-year FY2025 number at $8.3 million, up 4.99% from a year prior.
  • Common Equity hit $8.4 million in Q1 2026 for InflaRx, roughly flat from $8.3 million in the prior quarter.
  • Over the last five years, Common Equity for IFRX hit a ceiling of $110.4 million in Q4 2023 and a floor of $4.9 million in Q1 2022.
  • Historically, Common Equity has averaged $19.1 million across 5 years, with a median of $8.0 million in 2024.
  • Biggest five-year swings in Common Equity: soared 58.81% in 2023 and later plummeted 92.8% in 2024.
  • Tracing IFRX's Common Equity over 5 years: stood at $90.1 million in 2022, then rose by 22.45% to $110.4 million in 2023, then plummeted by 92.8% to $8.0 million in 2024, then grew by 4.99% to $8.3 million in 2025, then increased by 0.37% to $8.4 million in 2026.
  • Business Quant data shows Common Equity for IFRX at $8.4 million in Q1 2026, $8.3 million in Q4 2025, and $8.4 million in Q3 2025.